RA CAPITAL MANAGEMENT, L.P. - 23 May 2022 Form 4 Insider Report for Kala Pharmaceuticals, Inc. (KALA)

Role
10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
KALA
Transactions as of
23 May 2022
Net transactions value
-$1,488,844
Form type
4
Filing time
25 May 2022, 17:17:08 UTC
Previous filing
01 Jun 2022
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALA Common Stock Sale $812,500 -1,250,000 -11% $0.6500 9,624,613 23 May 2022 See Footnotes F1, F2, F7
transaction KALA Common Stock Sale $73,851 -144,805 -1.5% $0.5100 9,479,808 24 May 2022 See Footnotes F3, F4, F7
transaction KALA Common Stock Sale $602,494 -1,434,509 -15% $0.4200 8,045,299 25 May 2022 See Footnotes F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.60 to $0.72; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F2 These securities include 9,624,613 shares held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3 This transaction was executed in multiple trades at prices ranging from $0.50 to $0.55, the price reported above reflects the weighted average sale price.
F4 These securities include 9,479,808 shares held directly by the Fund.
F5 This transaction was executed in multiple trades at prices ranging from $0.40 to $0.52; the price reported above reflects the weighted average sale price.
F6 These securities include 8,045,299 shares held directly by the Fund.
F7 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.